Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $536.26 ($5.1M) on 2026-10-05, disclosed to the SEC on 2026-10-06.
Scheduled sale ($5.1M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $536.26 | 501 | $269K | 5.2% |
| 2 | $537.43 | 905 | $486K | 9.5% |
| 3 | $538.62 | 655 | $353K | 6.9% |
| 4 | $539.50 | 931 | $502K | 9.8% |
| 5 | $540.50 | 1,028 | $556K | 10.8% |
| 6 | $541.66 | 1,239 |
| $671K |
| 13.0% |
| 7 | $542.56 | 918 | $498K | 9.7% |
| 8 | $543.54 | 783 | $426K | 8.3% |
| 9 | $544.59 | 1,260 | $686K | 13.3% |
| 10 | $545.69 | 920 | $502K | 9.8% |
| 11 | $546.63 | 360 | $197K | 3.8% |
| Total | $541.64 avg | 9,500 | $5.1M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-14 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |